Compare Amylx Pharmaceuticals Inc (AMLX) vs C.H. Robinson Worldwide, Inc. (CHRW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs C.H. Robinson Worldwide, Inc. — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while C.H. Robinson Worldwide, Inc. trades at $145.4 (market cap $16.96B). The key difference: C.H. Robinson Worldwide, Inc. is far larger — about 6.4× Amylx Pharmaceuticals Inc's market cap, and C.H. Robinson Worldwide, Inc. pays a 1.74% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | CHRW | |
|---|---|---|
Market Cap | $2.64B | $16.96B |
Sector | Health | Industrials |
52-Week High | $24.19 | $209.42 |
52-Week Low | $7.82 | $118.77 |
Enterprise Value | $2.39B | $18.78B |
Dividend Yield | — | 1.74% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About C.H. Robinson Worldwide, Inc.
C.H. Robinson is a top-tier non-asset-based third-party logistics provider with a significant focus on domestic freight brokerage (57% of 2021 net revenue), which reflects mostly truck brokerage but also rail intermodal. Additionally, the firm also operates a large air and ocean forwarding division (34%), which has grown organically and via tuck-in acquisitions. The remainder of revenue consists of the European truck-brokerage division, transportation management services, and a legacy produce-sourcing operation.
Read more on CHRW →
